Cargando…

Diffuse 18F-FDG PET Uptake in a Patient With Biopsy-Proven ATTR Cardiac Amyloidosis: A Potential Pitfall in Interpretation

Detalles Bibliográficos
Autores principales:	Aldajani, Ahmed, Chetrit, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502433/ https://www.ncbi.nlm.nih.gov/pubmed/37720186 http://dx.doi.org/10.1016/j.cjco.2023.05.004

Ejemplares similares

Quality of life in ATTR amyloidosis
por: Lane, Thirusha, et al.
Publicado: (2015)

Guidelines for genetic counselling in ATTR amyloidosis
por: Sequeiros, Jorge
Publicado: (2015)

Heart transplantation in hereditary ATTR amyloidosis
por: Slama, M
Publicado: (2015)

Diagnosis and Treatment of AL and ATTR Amyloidosis
por: Faiman, Beth, et al.
Publicado: (2021)

Generalized Lymph Node Activation after Influenza Vaccination on (18)F FDG-PET/CT Imaging, an Important Pitfall in PET Interpretation
por: Ayati, Narjess, et al.
Publicado: (2017)

Electroanatomical features of biopsy-proven cardiac amyloidosis
por: Casella, M, et al.
Publicado: (2023)

Diffuse Intense (18)F-FDG Uptake at PET in Unilateral Breast Related to Breastfeeding Practice
por: Ko, Kyung Hee, et al.
Publicado: (2013)

The Value of Diffuse Splenic and Hepatic (18)F-FDG Uptake on PET/CT in Diagnosing Patients with Anemia
por: Deng, Li, et al.
Publicado: (2022)

ATTR Amyloidosis: development of cardiac symptoms during 6 years of follow up in different ATTR-variants
por: Klaassen, Sebastiaan, et al.
Publicado: (2015)

Benign Colonic (18)F-FDG Uptake on Whole-Body FDG-PET Scan
por: Jang, Byung Ik
Publicado: (2012)

Glavonoid, a possible supplement for prevention of ATTR amyloidosis
por: Matsushita, Hiroaki, et al.
Publicado: (2021)

Quality of life assessment in amyloid transthyretin (ATTR) amyloidosis
por: Aimo, Alberto, et al.
Publicado: (2021)

Conventional heart failure therapy in cardiac ATTR amyloidosis
por: Ioannou, Adam, et al.
Publicado: (2023)

Cardiac amyloidosis: diagnostic challenges and recent advancement in the treatment of transthyretin amyloidosis (ATTR)
por: Rahman, Tanvir, et al.
Publicado: (2021)

A Brief Journey through Protein Misfolding in Transthyretin Amyloidosis (ATTR Amyloidosis)
por: Gonzalez-Duarte, Alejandra, et al.
Publicado: (2021)

Uptake of [(18)F]DCFPyL in Paget's Disease of Bone, an Important Potential Pitfall in the Clinical Interpretation of PSMA PET Studies
por: Rowe, Steven P., et al.
Publicado: (2015)

Lung cancer combined with diffuse peritoneal and mesenteric amyloidosis detected on (18)F-FDG PET/CT: A case report
por: Wang, JianJie, et al.
Publicado: (2021)

(18)F-FBPA PET in Sarcoidosis: Comparison to Inflammation-Related Uptake on FDG PET
por: Watabe, Tadashi, et al.
Publicado: (2020)

Granulomatous dermatitis: a rare pitfall in lymphoma staging with [(18)F]FDG-PET/CT
por: Enke, Johanna S., et al.
Publicado: (2023)

(18)F-FDG PET/CT in Primary AL Hepatic Amyloidosis Associated with Multiple Myeloma
por: Son, Youn Mi, et al.
Publicado: (2011)

A Descriptive Analysis of ATTR Amyloidosis in Spain from the Transthyretin Amyloidosis Outcomes Survey
por: González-Moreno, Juan, et al.
Publicado: (2021)

The landscape of treatment of chronic kidney disease in hereditary ATTR amyloidosis
por: Lobato, Luisa
Publicado: (2015)

TUDCA as an autophagic modulator of ATTR V30M Amyloidosis
por: Teixeira, Cristina, et al.
Publicado: (2015)

The role of complement in ATTR amyloidosis: a new therapeutic avenue?
por: Panayiotou, Elena, et al.
Publicado: (2015)

Symptomatic therapy in ATTR amyloidosis: pain killers in TTR-FAP
por: Attal, Nadine
Publicado: (2015)

Hereditary ATTR Amyloidosis in Austria: Prevalence and Epidemiological Hot Spots
por: Auer-Grumbach, Michaela, et al.
Publicado: (2020)

Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy
por: Adams, David, et al.
Publicado: (2020)

Practice of Hereditary ATTR Amyloidosis in Non-endemic Areas of Japan
por: Matsushima, Masaaki, et al.
Publicado: (2022)

A (18)F-FDG PET/CT Screening Study of a Hepatocellular Carcinoma Patient with Diffuse (18)F-FDG Uptake into the Portal Vein and its Intrahepatic Branches
por: Koroglu, Reyhan, et al.
Publicado: (2016)

PET-CT for Evaluation of Spleen and Liver (18)F-FDG Diffuse Uptake Without Lymph Node Enlargement in Lymphoma
por: Rao, Liangjun, et al.
Publicado: (2016)

(18)F‐FDG PET/CT features of immune‐related adverse events and pitfalls following immunotherapy
por: Cherk, Martin H, et al.
Publicado: (2022)

(18)F-FDG-PET uptake in non-infected total hip prostheses
por: Gelderman, Stefan J, et al.
Publicado: (2018)

Spectrum of the Breast Lesions With Increased 18F-FDG Uptake on PET/CT
por: Dong, Aisheng, et al.
Publicado: (2016)

False-Positive (18)F-FDG PET/CT Uptake in Unilateral Lactation
por: Yip, Joshua Wei Liang, et al.
Publicado: (2020)

Lymphoma Severity and Type Are Associated With Aortic FDG Uptake by (18)F-FDG PET/CT Imaging
por: Vlachopoulos, Charalambos V., et al.
Publicado: (2020)

(18)F-FDG PET/CT in Patients with Nodular Pulmonary Amyloidosis: Case Report and Literature Review
por: Quan, Xiao-Qing, et al.
Publicado: (2014)

Pituitary (18)F-FDG uptake correlates with serum TSH levels in thyroid cancer patients on (18)F-FDG PET/CT
por: Ding, Yingli, et al.
Publicado: (2019)

Patient and family experience with transthyretin amyloid cardiomyopathy (ATTR-CM) and polyneuropathy (ATTR-PN) amyloidosis: results of two focus groups
por: Rintell, David, et al.
Publicado: (2021)

A predicting model of bone marrow malignant infiltration in (18)F-FDG PET/CT images with increased diffuse bone marrow FDG uptake
por: Zhou, Mingge, et al.
Publicado: (2018)

Pitfalls of FDG-PET in the prostate for the surgical oncologist
por: O'Connor, Ellen, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9d5pi4vmtn8mppk4falq3gjieg